speb/financial-data huggingface dataset:
CKI.L balance_sheet (annual, 2025-12-31) — Retained Earnings: 106560000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 106560000000.00
CKI.L cash_flow (annual, 2025-12-31) — Sale Of PPE: 2000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Share Issued: 2519610945.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 2519610945.00
CKI.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 137795000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 137795000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: 135705000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 135705000000.00
CKI.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CKI.L income_statement (annual, 2025-12-31) — Tax Provision: 165000000.00
CKI.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.02
CKI.L cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -147000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Assets: 166262000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 166262000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 155897000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 155897000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Debt: 20879000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 20879000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 137852000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 137852000000.00
CKI.L income_statement (annual, 2025-12-31) — Total Expenses: 4272000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 28410000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 28410000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 158105000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 158105000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 19241000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 19241000000.00
CKI.L income_statement (annual, 2025-12-31) — Total Other Finance Cost: -33000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Total Tax Payable: 54000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 54000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Work In Process: 34000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Work In Process: 34000000.00
CKI.L balance_sheet (annual, 2025-12-31) — Working Capital: -1012000000.00
CKI.L balance_sheet (quarterly, 2025-12-31) — Working Capital: -1012000000.00
CKI.TO balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 2773000.00
CKI.TO income_statement (annual, 2021-12-31) — Average Dilution Earnings: 1285000.00
CKI.TO cash_flow (annual, 2021-12-31) — Dividends Received Cfi: 914000.00
CKI.TO income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 30959000.00
CKI.TO balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 455000.00
CKI.TO balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 2773000.00
CKI.TO balance_sheet (annual, 2021-12-31) — Investments And Advances: 2773000.00
CKI.TO cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 66328000.00
CKI.TO balance_sheet (annual, 2021-12-31) — Other Payable: 8390000.00
CKI.TO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 1807000.00
CKI.TO cash_flow (annual, 2021-12-31) — Purchase Of Business: -21083000.00
CKI.TO cash_flow (annual, 2021-12-31) — Purchase Of Investment: -7005000.00
CKI.TO cash_flow (annual, 2021-12-31) — Sale Of Investment: 73333000.00
CKI.TO cash_flow (annual, 2021-12-31) — Sale Of PPE: 28000.00
CKI.TO income_statement (annual, 2022-12-31) — +Operating Expense: 54636000.00
CKI.TO income_statement (annual, 2022-12-31) — +Total Revenue: 59966000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 10802000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -17842000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 7302000.00
CKI.TO income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
CKI.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 14238000.00
CKI.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.23
CKI.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 18423000.00
CKI.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -19015000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 83190000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1090000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1090000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 1090000.00
CKI.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 686000.00
CKI.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
CKI.TO cash_flow (annual, 2022-12-31) — Change In Payable: 511000.00
CKI.TO cash_flow (annual, 2022-12-31) — Change In Receivables: 1492000.00
CKI.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 2689000.00
CKI.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -17333000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Common Stock: 83190000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 214970000.00
CKI.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -3775000.00
CKI.TO cash_flow (annual, 2022-12-31) — Depreciation: 9570000.00
CKI.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 9570000.00
CKI.TO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 9570000.00
CKI.TO income_statement (annual, 2022-12-31) — Depreciation Income Statement: 9570000.00
CKI.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 14238000.00
CKI.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.23
CKI.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 3226000.00
CKI.TO cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 1064000.00
CKI.TO cash_flow (annual, 2022-12-31) — End Cash Position: 1090000.00
CKI.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 16095000.00
CKI.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -15613000.00
CKI.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -319000.00
CKI.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 387000.00
CKI.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 42889000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 320000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 239546000.00
CKI.TO income_statement (annual, 2022-12-31) — Interest Expense: 6495000.00
CKI.TO income_statement (annual, 2022-12-31) — Interest Income: 670000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 373554000.00
CKI.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -36830000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Investment Properties: 80885000.00
CKI.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 39813000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 159144000.00
CKI.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 39813000.00
CKI.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -19871000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -345000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -3775000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Net Debt: 157494000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -240000.00
CKI.TO income_statement (annual, 2022-12-31) — Net Income: 3226000.00
CKI.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 3226000.00
CKI.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 3226000.00
CKI.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 3226000.00
CKI.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 3226000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 3226000.00
CKI.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 3226000.00
CKI.TO income_statement (annual, 2022-12-31) — Net Interest Income: -5825000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 3025000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 19942000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 19942000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -72000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -21559000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Net PPE: 221704000.00
CKI.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -19015000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 214970000.00
CKI.TO income_statement (annual, 2022-12-31) — Normalized Income: 2285436.40
CKI.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 3402000.00
CKI.TO income_statement (annual, 2022-12-31) — Operating Revenue: 59966000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 14069144.00
CKI.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 474000.00
CKI.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 2177000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Other Payable: 9374000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Payables: 22239000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1184000.00
CKI.TO income_statement (annual, 2022-12-31) — Pretax Income: 5330000.00
CKI.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -345000.00
CKI.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
CKI.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -19015000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Receivables: 6959000.00
CKI.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 9570000.00
CKI.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -19871000.00
CKI.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3775000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 41579000.00
CKI.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CKI.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 3025000.00
CKI.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CKI.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 42889000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Share Issued: 14069144.00
CKI.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 214970000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 214970000.00
CKI.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 613436.40
CKI.TO income_statement (annual, 2022-12-31) — Tax Provision: 2104000.00
CKI.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.39
CKI.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1082000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Total Assets: 416121000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 373554000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Total Debt: 159144000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 214970000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 201151000.00
CKI.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2063000.00
CKI.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 1554000.00
CKI.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1554000.00
CKI.TO income_statement (annual, 2023-12-31) — +Operating Expense: 56860000.00
CKI.TO income_statement (annual, 2023-12-31) — +Total Revenue: 61973000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 11427000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -24690000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 7302000.00
CKI.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 14004000.00
CKI.TO income_statement (annual, 2023-12-31) — Basic EPS: 0.24
CKI.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1090000.00
CKI.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -9263000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 82574000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 929000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 929000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 929000.00
CKI.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 458000.00
CKI.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
CKI.TO cash_flow (annual, 2023-12-31) — Change In Payable: -1345000.00
CKI.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 885000.00
CKI.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -2000.00
CKI.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -161000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Common Stock: 82574000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 230689000.00
CKI.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -1482000.00
CKI.TO cash_flow (annual, 2023-12-31) — Depreciation: 10179000.00
CKI.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 10179000.00
CKI.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 10179000.00
CKI.TO income_statement (annual, 2023-12-31) — Depreciation Income Statement: 10179000.00
CKI.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 14004000.00
CKI.TO income_statement (annual, 2023-12-31) — Diluted EPS: 0.24
CKI.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 3424000.00
CKI.TO cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 1049000.00
CKI.TO cash_flow (annual, 2023-12-31) — End Cash Position: 929000.00
CKI.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 16616000.00
CKI.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -1106000.00
CKI.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -279000.00
CKI.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 0.00
CKI.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 50750000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 231616000.00
CKI.TO income_statement (annual, 2023-12-31) — Interest Expense: 7187000.00
CKI.TO income_statement (annual, 2023-12-31) — Interest Income: 4000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 356473000.00
CKI.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -24934000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Investment Properties: 138486000.00
CKI.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 88896000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 126176000.00
CKI.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 88896000.00
CKI.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -70798000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 15863000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1482000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Net Debt: 124855000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
CKI.TO income_statement (annual, 2023-12-31) — Net Income: 3424000.00
CKI.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 3424000.00
CKI.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 3424000.00
CKI.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 3424000.00
CKI.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 3424000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 3424000.00
CKI.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 3424000.00
CKI.TO income_statement (annual, 2023-12-31) — Net Interest Income: -7183000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 18098000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 18098000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
CKI.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -32583000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Net PPE: 206926000.00
CKI.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -9263000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 230689000.00
CKI.TO income_statement (annual, 2023-12-31) — Normalized Income: 5792607.08
CKI.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 8157000.00
CKI.TO income_statement (annual, 2023-12-31) — Operating Revenue: 61973000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 13959157.00
CKI.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -241000.00
CKI.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: -4069000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Payables: 11427000.00
CKI.TO income_statement (annual, 2023-12-31) — Pretax Income: 5113000.00
CKI.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CKI.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -9263000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Receivables: 3150000.00
CKI.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 10179000.00
CKI.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -70798000.00
CKI.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1482000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 44221000.00
CKI.TO cash_flow (annual, 2023-12-31) — Sale Of Business: 15863000.00
CKI.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CKI.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 50750000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Share Issued: 13959157.00
CKI.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 230689000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 230689000.00
CKI.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1168392.92
CKI.TO income_statement (annual, 2023-12-31) — Tax Provision: 1689000.00
CKI.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.33
CKI.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 990000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Total Assets: 395130000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 356473000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Total Debt: 126176000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 230689000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 164441000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
CKI.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -3537000.00
CKI.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3537000.00
CKI.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CKI.TO balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -30335000.00
CKI.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 13951000.00
CKI.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.87
CKI.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 13951000.00
CKI.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.87
CKI.TO cash_flow (quarterly, 2024-09-30) — Dividends Received Cfi: 0.00
CKI.TO balance_sheet (quarterly, 2024-09-30) — Gross PPE: 254855000.00
CKI.TO cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
CKI.TO cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
CKI.TO balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 0.00
CKI.TO income_statement (annual, 2024-12-31) — +Operating Expense: 60455000.00
CKI.TO income_statement (annual, 2024-12-31) — +Total Revenue: 106781000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 7674000.00
CKI.TO balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 7674000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -28026000.00
CKI.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -28026000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 7302000.00
CKI.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 13956000.00
CKI.TO income_statement (annual, 2024-12-31) — Basic EPS: 2.71
CKI.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 929000.00
CKI.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -13681000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 82528000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 809000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 809000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 809000.00
CKI.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -589000.00
CKI.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
CKI.TO cash_flow (annual, 2024-12-31) — Change In Payable: 2862000.00
CKI.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -2445000.00
CKI.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -172000.00
CKI.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -120000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Common Stock: 82528000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 276942000.00
CKI.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -125000.00
CKI.TO cash_flow (annual, 2024-12-31) — Depreciation: 10563000.00
CKI.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 10563000.00
CKI.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 10563000.00
CKI.TO income_statement (annual, 2024-12-31) — Depreciation Income Statement: 10563000.00
CKI.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 13956000.00
CKI.TO income_statement (annual, 2024-12-31) — Diluted EPS: 2.71
CKI.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 37823000.00
CKI.TO cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 0.00
CKI.TO cash_flow (quarterly, 2024-12-31) — Dividends Received Cfi: 0.00
CKI.TO cash_flow (annual, 2024-12-31) — End Cash Position: 809000.00
CKI.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 63032000.00
CKI.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 4202000.00
CKI.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -34000000.00
CKI.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 46430000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 252156000.00
CKI.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 252156000.00
CKI.TO income_statement (annual, 2024-12-31) — Interest Expense: 7531000.00
CKI.TO income_statement (annual, 2024-12-31) — Interest Income: 876000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 461583000.00
CKI.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -81035000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Investment Properties: 249133000.00
CKI.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 66170000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 185234000.00
CKI.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 66170000.00
CKI.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -3013000.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CKI.TO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -125000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Net Debt: 183832000.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -102000.00
CKI.TO cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
CKI.TO income_statement (annual, 2024-12-31) — Net Income: 37823000.00
CKI.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 37823000.00
CKI.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 37823000.00
CKI.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 37823000.00
CKI.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 37823000.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 37823000.00
CKI.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 37823000.00
CKI.TO income_statement (annual, 2024-12-31) — Net Interest Income: -6655000.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 63157000.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 63157000.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 0.00
CKI.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -67354000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Net PPE: 224130000.00
CKI.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -13681000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 276942000.00
CKI.TO income_statement (annual, 2024-12-31) — Normalized Income: 6879432.67
CKI.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 17883000.00
CKI.TO income_statement (annual, 2024-12-31) — Operating Revenue: 106781000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 13951357.00
CKI.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3771000.00
CKI.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 3462000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Other Payable: 6268000.00
CKI.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 6268000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Payables: 14040000.00
CKI.TO income_statement (annual, 2024-12-31) — Pretax Income: 46326000.00
CKI.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -13681000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Receivables: 3553000.00
CKI.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 10563000.00
CKI.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3013000.00
CKI.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -125000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 81965000.00
CKI.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CKI.TO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
CKI.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
CKI.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 46430000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Share Issued: 13951357.00
CKI.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 276942000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 276942000.00
CKI.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 6956432.67
CKI.TO income_statement (annual, 2024-12-31) — Tax Provision: 8503000.00
CKI.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.18
CKI.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 2849000.00
CKI.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 2849000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Total Assets: 516378000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 461583000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Total Debt: 185234000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 276942000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 239436000.00
CKI.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 98000.00
CKI.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 37900000.00
CKI.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 29900000.00
CKI.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 37900000.00
CKI.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 29900000.00
CKI.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 18194000.00
CKI.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 14964000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7302000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 13940000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.17
CKI.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 809000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2205000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 82240000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1019000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1019000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1019000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -835000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: -853000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2518000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -4206000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 210000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 82240000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 278862000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1097000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 2875000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2875000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2875000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 2875000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 13940000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.17
CKI.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2359000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 1019000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 24297000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3770000.00
CKI.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11984000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 2986000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Interest Income: 11000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 488924000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -22522000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Investment Properties: 271158000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 25986000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 210643000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 25986000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -592000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1097000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 209043000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
CKI.TO income_statement (quarterly, 2025-03-31) — Net Income: -2359000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2359000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2359000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2359000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2359000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2359000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2359000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -2975000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 25394000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 25394000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 0.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -20317000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 224520000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2205000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 278862000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -2359000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1565000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 14964000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 13902657.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2125000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3335000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 8002000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Payables: 8100000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -3230000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2205000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 8920000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2875000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -592000.00
CKI.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1097000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 78797000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 11984000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 13902657.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 278862000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 278862000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CKI.TO income_statement (quarterly, 2025-03-31) — Tax Provision: -871000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
CKI.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 546745000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 488924000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 210643000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 278862000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 267883000.00
CKI.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 98000.00
CKI.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CKI.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CKI.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 16264000.00
CKI.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 16388000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7302000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 13771000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.01
CKI.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1019000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3648000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 80750000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 994000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 994000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 994000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1475000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 448000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1249000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2276000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -25000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 80750000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 271808000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -5638000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 2921000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2921000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2921000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 2921000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 13771000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.01
CKI.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -84000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 994000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 27734000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3863000.00
CKI.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 12411000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 3151000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Interest Income: 11000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 515391000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -27544000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Investment Properties: 299505000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 152625000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 244153000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 152625000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -119253000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -5638000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 242589000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 0.00
CKI.TO income_statement (quarterly, 2025-06-30) — Net Income: -84000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -84000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -84000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -84000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -84000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -84000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -84000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -3140000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 33372000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 33372000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -24752000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 223318000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3648000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 271808000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -84000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -215000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 16388000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 13650857.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -776000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 932000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 8899000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Payables: 8947000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 124000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3648000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 11669000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2921000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -119253000.00
CKI.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -5638000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 74565000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 12411000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 13650857.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 271808000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 271808000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CKI.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 208000.00
CKI.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
CKI.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 576992000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 515391000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 244153000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 271808000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 305184000.00
CKI.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 48000.00
CKI.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 15212000.00
CKI.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 36295000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7302000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 13651000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 1.16
CKI.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 994000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3596000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 80750000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 559000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 559000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 559000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 630000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: -693000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 2392000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2329000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -435000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 80750000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 289721000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 3006000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3006000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 3006000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 3006000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 13651000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.16
CKI.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 15824000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 559000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 16355000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 9105000.00
CKI.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 11187000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 2395000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Interest Income: 28000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 549644000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -29491000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Investment Properties: 347003000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 16852000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 260480000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 16852000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -497000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 259364000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 0.00
CKI.TO income_statement (quarterly, 2025-09-30) — Net Income: 15824000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 15824000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 15824000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 15824000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 15824000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 15824000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 15824000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -2367000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 16355000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 16355000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -25915000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 224613000.00
CKI.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -3576000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 289721000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 5766531.90
CKI.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 12701000.00
CKI.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 36295000.00
CKI.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 13650857.00